Nearly 2,000 Pa. consumers to get a share of $3M biopharm firm settlement

Nearly 2,000 Pennsylvania consumers will receive a share of a $3 million settlement the state negotiated with Chester County biopharmaceutical company Cephalon Inc.. The Cephalon settlement, entered into by a coalition of 47 attorneys general, resolves claims that the company violated antitrust and consumer protection laws by delaying the entry of lower-cost generic versions of Provigil into the marketplace, and that the company made misrepresentations to the U.S. Patent& Trademark Office. Provigil…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news